280 related articles for article (PubMed ID: 31868078)
1. Hemoadsorption by extracorporeal cytokine adsorption therapy (CytoSorb
Singh YP; Chhabra SC; Lashkari K; Taneja A; Garg A; Chandra A; Chhabra M; Singh GP; Jain S
Int J Artif Organs; 2020 Jun; 43(6):372-378. PubMed ID: 31868078
[TBL] [Abstract][Full Text] [Related]
2. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb
Paul R; Sathe P; Kumar S; Prasad S; Aleem M; Sakhalvalkar P
World J Crit Care Med; 2021 Jan; 10(1):22-34. PubMed ID: 33505870
[TBL] [Abstract][Full Text] [Related]
3. Hemoadsorption by CytoSorb in septic patients: a case series.
Kogelmann K; Jarczak D; Scheller M; Drüner M
Crit Care; 2017 Mar; 21(1):74. PubMed ID: 28343448
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study.
Hawchar F; László I; Öveges N; Trásy D; Ondrik Z; Molnar Z
J Crit Care; 2019 Feb; 49():172-178. PubMed ID: 30448517
[TBL] [Abstract][Full Text] [Related]
5. Hemoperfusion with Cytosorb in pediatric patients with septic shock: A retrospective observational study.
Bottari G; Guzzo I; Marano M; Stoppa F; Ravà L; Di Nardo M; Cecchetti C
Int J Artif Organs; 2020 Sep; 43(9):587-593. PubMed ID: 32003289
[TBL] [Abstract][Full Text] [Related]
6. Hemoadsorption treatment with CytoSorb
Träger K; Skrabal C; Fischer G; Schroeder J; Marenski L; Liebold A; Reinelt H; Datzmann T
Int J Artif Organs; 2020 Jun; 43(6):422-429. PubMed ID: 31868089
[TBL] [Abstract][Full Text] [Related]
7. Benefit of Hemoadsorption Therapy in Patients Suffering Sepsis-Associated Acute Kidney Injury: A Case Series.
Hakemi MS; Nassiri AA; Nobakht A; Mardani M; Darazam IA; Parsa M; Miri MM; Shahrami R; Koomleh AA; Entezarmahdi K; Karimi A
Blood Purif; 2022; 51(10):823-830. PubMed ID: 35108714
[TBL] [Abstract][Full Text] [Related]
8. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study.
Brouwer WP; Duran S; Kuijper M; Ince C
Crit Care; 2019 Sep; 23(1):317. PubMed ID: 31533846
[TBL] [Abstract][Full Text] [Related]
9. High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock: A retrospective cohort study.
Schultz P; Schwier E; Eickmeyer C; Henzler D; Köhler T
J Crit Care; 2021 Aug; 64():184-192. PubMed ID: 33962219
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study.
Friesecke S; Stecher SS; Gross S; Felix SB; Nierhaus A
J Artif Organs; 2017 Sep; 20(3):252-259. PubMed ID: 28589286
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery.
Boss K; Jahn M; Wendt D; Haidari Z; Demircioglu E; Thielmann M; Ruhparwar A; Kribben A; Tyczynski B
PLoS One; 2021; 16(2):e0246299. PubMed ID: 33556101
[TBL] [Abstract][Full Text] [Related]
12. Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): protocol of a prospective, randomised, adaptive, multicentre clinical trial.
Kanjo A; Molnar Z; Zádori N; Gede N; Erőss B; Szakó L; Kiss T; Márton Z; Malbrain MLNG; Szuldrzynski K; Szrama J; Kusza K; Kogelmann K; Hegyi P
BMJ Open; 2021 Aug; 11(8):e050464. PubMed ID: 34446497
[TBL] [Abstract][Full Text] [Related]
13. Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study.
Basu R; Pathak S; Goyal J; Chaudhry R; Goel RB; Barwal A
Indian J Crit Care Med; 2014 Dec; 18(12):822-4. PubMed ID: 25538418
[TBL] [Abstract][Full Text] [Related]
14. First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report.
Bruenger F; Kizner L; Weile J; Morshuis M; Gummert JF
Int J Artif Organs; 2015 Feb; 38(2):113-6. PubMed ID: 25656010
[TBL] [Abstract][Full Text] [Related]
15. Clinical Utility of Extracorporeal Cytokine Hemoadsorption Therapy: A Literature Review.
Bonavia A; Groff A; Karamchandani K; Singbartl K
Blood Purif; 2018; 46(4):337-349. PubMed ID: 30176653
[TBL] [Abstract][Full Text] [Related]
16. Experience with hemoadsorption (CytoSorb
Mehta Y; Mehta C; Kumar A; George JV; Gupta A; Nanda S; Kochhar G; Raizada A
World J Crit Care Med; 2020 Jan; 9(1):1-12. PubMed ID: 32104647
[TBL] [Abstract][Full Text] [Related]
17. Blood Purification With CytoSorb in Critically Ill Patients: Single-Center Preliminary Experience.
Calabrò MG; Febres D; Recca G; Lembo R; Fominskiy E; Scandroglio AM; Zangrillo A; Pappalardo F
Artif Organs; 2019 Feb; 43(2):189-194. PubMed ID: 30156308
[TBL] [Abstract][Full Text] [Related]
18. [Study the effects of high-volume hemofiltration and fluid resuscitation on removing blood lactic acid and pro-inflammatory cytokines in patients with refractory septic shock].
Wang CT; Ren HS; Jiang JJ; Zhang JC; Meng M; Yu JB; Chu YF; Ding M
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jul; 21(7):421-4. PubMed ID: 19615135
[TBL] [Abstract][Full Text] [Related]
19. Observational case series: six neurosurgical patients with septic shock demonstrating clinical improvement after a combination of standard care and blood purification.
Burov AI; Abramov TA; Kostritca NS; Korotkov DS; Danilov GV; Strunina YV; Savin IA
Eur J Med Res; 2021 Dec; 26(1):151. PubMed ID: 34930484
[TBL] [Abstract][Full Text] [Related]
20. Effects of the timing and intensity of treatment on septic shock patients treated with CytoSorb
Berlot G; Samola V; Barbaresco I; Tomasini A; di Maso V; Bianco F; Gerini U
Int J Artif Organs; 2022 Mar; 45(3):249-253. PubMed ID: 35075942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
